Cell & molecular pathologist by training. Enjoy learning innovation in Pharma, Biotech, Edge, Quantum,Nanotech and Fintech. Just my own ideas/NOT invest advise.
$IONQ
"We have something for you."
A serving U.S. Navy cyber director cryptography & post-quantum portfolio wrote that in the comments under Katie Arrington's post this week.
Who is she? In November 2025, as acting CIO of the Department of War, Katie Arrington signed the memo ordering the entire Pentagon to inventory its cryptography and migrate to post-quantum.
Weeks later she left for IonQ - "because I saw where the train was stopping next on national security."
On June 22, the President signed the national version: "Securing the Nation Against Advanced Cryptographic Attacks."
She wrote the Pentagon's playbook. Now it's the country's and the Navy's already in her replies.
Keep an eye on this 😉
@Rick101284 👏🤝
#IonQ #Quantum #PostQuantum
IonQ's partnered directly with QEDMA using @awscloud Braket Direct to accomplish a milestone demonstration of their error mitigation software. Read the blog to learn more and reach out to leverage Braket Direct for your quantum use cases today.
https://t.co/28zlmzBu1N
Announcing IonQ Forte successfully passed the #AQ 35 benchmark suite, achieving our 2024 technical target one year ahead of schedule. Learn more about the technical breakthroughs behind the new benchmark on our blog:
https://t.co/iXHMVDG1EI
Hey, Silicon Valley! Join CEO @NoelGoddard2 at the Q2B23 conference on December 5, where she'll be sharing the latest updates on GothamQ, our #quantumnetworking testbed in New York: https://t.co/2Xk1tEHMhh @QCWare
Yesterday, @DeloitteTMT announced @IonQ_Inc is a 2023 Deloitte Technology Fast 500 winner!
IonQ is the fastest growing hardware company and the only quantum computing company to make the list!
See the full announcement here: https://t.co/rtXqLcD0JW
$BNGO - Bionano
Another student on our planet, Marina Munné Surroca, completes her master thesis at the University of Barcelona, Spain, with OGM as her main subject :
"Analysis of the usefulness of Optical Genome Mapping for the detection of clinically relevant chromosomal alterations and genomic complexity in patients with CLL"
Excellent !
https://t.co/Cpla2baEHq?
🧪APPROVED—The FDA has now authorized #Novavax’s new XBB-variant booster shot for use in all ages 12+. Anyone previously vaccinated with a #COVID19 vaccine (any brand) are eligible to receive one dose, and unvaccinated may receive 2 doses. #CovidIsNotOver
https://t.co/UXvw4b4jcc
$NVAX and the story continues #data results among the best since #COVID, BUT #shorts interest pressured from the #BigPharma , #hedge, gov interests. Amazing have best #malariavaccine#TheWHO+ #FDA approval for COVID and the price drops!!! ?? Clearly not the usual among pharma
#NVAX and the story continues #data results among the best since #COVID, BUT #shorts interest pressured from the #BigPharma , #hedge, gov interests. Amazing have best #malariavaccine#TheWHO+ #FDA approval for COVID and the price drops!!! ?? Clearly not the usual among pharma
$BNGO - Bionano
8-Sep-2023
Research Canada, is advertising the fact that the University Health Network (UHN) of Toronto is the first laboratory in Canada to use OGM as Standard of Care to diagnose Acute Myeloid Leukemia.
This is important as Research Canada is an advocacy alliance which pushes for health research and the adoption of new technologies in Canada by engaging with government, health departments, the media, and policy makers, so their pushing for OGM adoption is major.
https://t.co/qfxXjnzWFt
Analyses of 1,277 human brain proteomes reveal the extent of sex differences in the brain and identify genes associated with neuropsychiatric diseases that have differential regulation between males and females @wingolab @EmoryMedicine
https://t.co/HCvP7OXo4u
$BNGO 📣🔥PR NEWS DROP: Bionano Laboratories Receives College of American Pathologists (CAP) Accreditation for its Clinical Laboratory (This would be some good news) #BNGO#Bionano#OGM#CAP
SAN DIEGO, Aug. 16, 2023 (GLOBE NEWSWIRE) -- Bionano Laboratories, a laboratory services business of Bionano Genomics, Inc. (Nasdaq: BNGO), today announced that it has received Laboratory Accreditation from the College of American Pathologists (CAP) for its Clinical Laboratory Improvement Amendments (CLIA)-certified reference lab. CAP accreditation is awarded to laboratories that meet stringent requirements and maintain the highest standards for laboratory operations of quality, accuracy, and consistency, as outlined by CAP.
https://t.co/K3XMoyi7Nb
$BNGO - Bionano
16-Aug-2023 - (Cross species)
Scientists from the Emory University School of Medicine @ Atlanta and Rutgers University @ Piscataway investigating the genetic risk factors for schizophrenia, publish a paper based on investigations of mouse models titled :
"Cross-species analysis identifies mitochondrial dysregulation as a functional consequence of the schizophrenia-associated 3q29 deletion"
Bionano OGM used to call structural variants alongside Illumina and 10x Genomics sequencing.
https://t.co/ozDUa7uIgl